CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.

Perdagangan Angion Biomedica Corp. - ANGN CFD

0.5178
6.81%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.0644
Biaya inap posisi Long

Long position overnight fee


Margin. Your investment $1,000.00
Biaya Overnight -0.024874 %
Charges from borrowed part ($-0.99)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Kunjungi platform
-0.024874%
Biaya inap posisi short

Short position overnight fee


Margin. Your investment $1,000.00
Biaya Overnight 0.002651 %
Charges from borrowed part ($0.11)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Kunjungi platform
0.002651%
Waktu biaya inap 21:00 (UTC)
Kuantitas min. yang diperdagangkan 1
Mata uang USD
Margin 20%
Bursa efek United States of America
Komisi perdagangan 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 0.4848
Open* 0.5402
1-Year Change* -72.58%
Day's Range* 0.5014 - 0.5471
52 wk Range 0.46-2.37
Average Volume (10 days) 17.70K
Average Volume (3 months) 1.40M
Market Cap 15.32M
P/E Ratio -100.00K
Shares Outstanding 30.11M
Revenue 2.30M
EPS -1.29
Dividend (Yield %) N/A
Beta -100.00K
Next Earnings Date Mar 31, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 30, 2023 0.4848 0.0072 1.51% 0.4776 0.5475 0.4688
Mar 29, 2023 0.4887 0.0197 4.20% 0.4690 0.4887 0.4688
Mar 28, 2023 0.4642 -0.0146 -3.05% 0.4788 0.4788 0.4642
Mar 27, 2023 0.4799 0.0009 0.19% 0.4790 0.5252 0.4786
Mar 24, 2023 0.4885 -0.0390 -7.39% 0.5275 0.5276 0.4884
Mar 23, 2023 0.5307 0.0028 0.53% 0.5279 0.5374 0.5238
Mar 22, 2023 0.4887 0.0096 2.00% 0.4791 0.4890 0.4791
Mar 21, 2023 0.4789 0.0248 5.46% 0.4541 0.4791 0.4493
Mar 20, 2023 0.4881 0.0001 0.02% 0.4880 0.4986 0.4739
Mar 17, 2023 0.4887 -0.0490 -9.11% 0.5377 0.5378 0.4823
Mar 16, 2023 0.5081 0.0198 4.05% 0.4883 0.5695 0.4883
Mar 15, 2023 0.4930 -0.0542 -9.90% 0.5472 0.5671 0.4888
Mar 14, 2023 0.5372 -0.0196 -3.52% 0.5568 0.5963 0.5372
Mar 13, 2023 0.5377 -0.0240 -4.27% 0.5617 0.5621 0.5208
Mar 10, 2023 0.5132 -0.0641 -11.10% 0.5773 0.5778 0.5054
Mar 9, 2023 0.5568 -0.0604 -9.79% 0.6172 0.6256 0.5375
Mar 8, 2023 0.5960 0.0078 1.33% 0.5882 0.6158 0.5882
Mar 7, 2023 0.6060 -0.0094 -1.53% 0.6154 0.6155 0.6056
Mar 6, 2023 0.6256 -0.0208 -3.22% 0.6464 0.6466 0.6079
Mar 3, 2023 0.6156 0.0290 4.94% 0.5866 0.6258 0.5865

Angion Biomedica Corp. Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 2.301 28.312 2.88 1.487 4.029
Revenue 2.301 28.312 2.88 1.487 4.029
Cost of Revenue, Total 0 0.433 1.19 0.64 0.378
Gross Profit 2.301 27.879 1.69 0.847 3.651
Total Operating Expense 41.922 66.714 58.153 40.078 18.371
Selling/General/Admin. Expenses, Total 14.637 18.488 17.986 9.601 5.391
Research & Development 18.1 48.698 38.977 29.837 12.602
Operating Income -39.621 -38.402 -55.273 -38.591 -14.342
Interest Income (Expense), Net Non-Operating 0.719 -2.191 -8.249 0.488 0.401
Other, Net 0.095 -13.98 -16.527 -2.555 -6.084
Net Income Before Taxes -38.807 -54.573 -80.107 -40.658 -20.025
Net Income After Taxes -38.807 -54.573 -80.107 -40.658 -20.025
Net Income Before Extra. Items -38.807 -54.573 -80.107 -40.658 -20.025
Net Income -38.807 -54.573 -80.107 -40.658 -20.025
Total Adjustments to Net Income 0 -4.98
Income Available to Common Excl. Extra. Items -38.807 -54.573 -80.107 -40.658 -25.005
Income Available to Common Incl. Extra. Items -38.807 -54.573 -80.107 -40.658 -25.005
Diluted Net Income -38.807 -54.573 -80.107 -40.658 -25.005
Diluted Weighted Average Shares 30.0407 28.2448 14.7621 9.97635 9.97635
Diluted EPS Excluding Extraordinary Items -1.29181 -1.93214 -5.42652 -4.07544 -2.50643
Dividends per Share - Common Stock Primary Issue 0 0
Diluted Normalized EPS -0.98606 -1.96418 -5.4226 -4.07544 -2.50643
Gain (Loss) on Sale of Assets 0 -0.058
Unusual Expense (Income) 9.185 -0.905
Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
Total revenue 0 0 0.653 1.648 25.941
Revenue 0 0 0.653 1.648 25.941
Cost of Revenue, Total 0.433
Gross Profit 25.508
Total Operating Expense 7.051 9.05 9.688 16.133 11.307
Selling/General/Admin. Expenses, Total 3.745 3.315 3.615 4.466 4.206
Research & Development 0.16 2.938 6.073 11.667 6.668
Operating Income -7.051 -9.05 -9.035 -14.485 14.634
Interest Income (Expense), Net Non-Operating 0.606 0.053 -0.146 0.206 -0.016
Other, Net 0.005 0.009 0.042 0.039 0.272
Net Income Before Taxes -6.44 -8.988 -9.139 -14.24 14.89
Net Income After Taxes -6.44 -8.988 -9.139 -14.24 14.89
Net Income Before Extra. Items -6.44 -8.988 -9.139 -14.24 14.89
Net Income -6.44 -8.988 -9.139 -14.24 14.89
Income Available to Common Excl. Extra. Items -6.44 -8.988 -9.139 -14.24 14.89
Income Available to Common Incl. Extra. Items -6.44 -8.988 -9.139 -14.24 14.89
Diluted Net Income -6.44 -8.988 -9.139 -14.24 14.89
Diluted Weighted Average Shares 30.1146 30.1134 29.9739 29.9592 29.9654
Diluted EPS Excluding Extraordinary Items -0.21385 -0.29847 -0.3049 -0.47531 0.49691
Dividends per Share - Common Stock Primary Issue 0 0 0
Diluted Normalized EPS -0.10938 -0.20559 -0.3049 -0.47531 0.49691
Unusual Expense (Income) 3.146 2.797 0 0
Gain (Loss) on Sale of Assets 0
  • Annual
  • Quarterly
2021 2020 2019 2018
Total Current Assets 91.247 42.297 6.106 25.679
Cash and Short Term Investments 88.756 34.607 5.571 25.512
Cash & Equivalents 88.756 34.607 5.571 25.512
Total Receivables, Net 0.806 5 0.44 0.107
Prepaid Expenses 1.031 0.352 0.095 0.06
Total Assets 96.513 47.347 11.886 26.628
Property/Plant/Equipment, Total - Net 4.437 4.228 4.781 0.017
Property/Plant/Equipment, Total - Gross 4.954 4.654 5.109 0.295
Accumulated Depreciation, Total -0.517 -0.426 -0.328 -0.278
Long Term Investments 0.723 0.822 0.999 0.932
Total Current Liabilities 11.296 107.449 26.575 7.355
Accounts Payable 4.71 5.578 11.239 0.534
Accrued Expenses 4.113 7.276 3.694 2.98
Notes Payable/Short Term Debt 0 51.43 5.848 0
Other Current Liabilities, Total 2.415 43.165 5.794 3.841
Total Liabilities 15.006 137.796 30.472 7.717
Total Long Term Debt 0.235 0.635 0 0
Other Liabilities, Total 3.475 29.712 3.897 0.362
Total Equity 81.507 -90.449 -18.586 18.911
Preferred Stock - Non Redeemable, Net 0 0 0
Common Stock 0.3 0.156 0.095 0.094
Additional Paid-In Capital 296.445 72.136 63.584 60.138
Retained Earnings (Accumulated Deficit) -215.135 -160.562 -80.455 -39.797
Treasury Stock - Common 0 -1.846 -1.81 -1.524
Total Liabilities & Shareholders’ Equity 96.513 47.347 11.886 26.628
Total Common Shares Outstanding 29.9591 15.3167 9.97635 9.97635
Other Current Assets, Total 0.654 2.338
Long Term Debt 0 0.635
Other Equity, Total -0.103 -0.333
Other Long Term Assets, Total 0.106
Current Port. of LT Debt/Capital Leases 0.058
Capital Lease Obligations 0.235
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Total Current Assets 76.239 91.247 104.393 119.702 133.498
Cash and Short Term Investments 73.002 88.756 102.736 117.313 130.456
Cash & Equivalents 73.002 88.756 102.736 117.313 130.456
Total Receivables, Net 0 0.806 0 0 0
Prepaid Expenses 0.021 1.031 1.018 1.761 2.343
Other Current Assets, Total 3.216 0.654 0.639 0.628 0.699
Total Assets 81.258 96.513 109.94 125.359 139.2
Property/Plant/Equipment, Total - Net 4.209 4.437 4.652 4.776 4.787
Property/Plant/Equipment, Total - Gross 4.758 4.954 5.137 5.231 5.219
Accumulated Depreciation, Total -0.549 -0.517 -0.485 -0.455 -0.432
Long Term Investments 0.732 0.723 0.862 0.843 0.877
Other Long Term Assets, Total 0.078 0.106 0.033 0.038 0.038
Total Current Liabilities 10.381 11.296 17.946 20.524 16.963
Accounts Payable 3.433 4.71 7.679 9.307 6.69
Accrued Expenses 6.16 4.113 6.219 5.522 4.872
Notes Payable/Short Term Debt 0 0 0 0 0.895
Other Current Liabilities, Total 0.728 2.415 4.048 5.695 4.506
Total Liabilities 14.056 15.006 45.426 48.17 46.757
Total Long Term Debt 0.219 0.235 0 0 0
Long Term Debt 0 0 0 0
Other Liabilities, Total 3.456 3.475 27.48 27.646 29.794
Total Equity 67.202 81.507 64.514 77.189 92.443
Common Stock 0.3 0.3 0.304 0.303 0.3
Additional Paid-In Capital 296.476 296.445 298.518 295.636 292.67
Retained Earnings (Accumulated Deficit) -229.375 -215.135 -230.025 -214.321 -197.249
Treasury Stock - Common 0 -4.21 -4.21 -2.991
Other Equity, Total -0.199 -0.103 -0.073 -0.219 -0.287
Total Liabilities & Shareholders’ Equity 81.258 96.513 109.94 125.359 139.2
Total Common Shares Outstanding 29.9594 29.9591 29.9331 29.7976 29.6605
Current Port. of LT Debt/Capital Leases 0.06 0.058
Capital Lease Obligations 0.219 0.235
  • Annual
  • Quarterly
2021 2020 2019 2018
Net income/Starting Line -54.573 -80.107 -40.658 -20.025
Cash From Operating Activities -52.643 -22.888 -24.589 -8.02
Cash From Operating Activities 0.091 0.098 0.05 0.002
Non-Cash Items 27.809 31.352 6.269 9.051
Cash Taxes Paid 0 0
Cash Interest Paid 0.007 0 0
Changes in Working Capital -25.97 25.769 9.75 2.952
Cash From Investing Activities -0.382 -0.041 -0.242 0
Capital Expenditures -0.382 -0.041 -0.242 0
Cash From Financing Activities 107.171 52.409 4.89 31.741
Issuance (Retirement) of Stock, Net -0.617 20.813 -0.375 28.596
Issuance (Retirement) of Debt, Net 0.293 32.118 5.265 3.145
Net Change in Cash 54.149 29.036 -19.941 23.721
Financing Cash Flow Items 107.495 -0.522
Foreign Exchange Effects 0.003 -0.444
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -14.24 -54.573 -69.463 -53.759 -36.687
Cash From Operating Activities -15.653 -52.643 -38.281 -23.082 -12.551
Cash From Operating Activities 0.032 0.091 0.059 0.029 0.006
Non-Cash Items 0.179 27.809 25.729 23.505 21.675
Changes in Working Capital -1.624 -25.97 5.394 7.143 2.455
Cash From Investing Activities 0 -0.382 -0.346 -0.285 -0.041
Capital Expenditures 0 -0.382 -0.346 -0.285 -0.041
Cash From Financing Activities -0.014 107.171 106.767 106.068 108.444
Financing Cash Flow Items 0 107.495 -5.52 -5.428 -2.797
Issuance (Retirement) of Stock, Net 0 -0.617 112.287 111.496 111.241
Issuance (Retirement) of Debt, Net -0.014 0.293 0 0 0
Foreign Exchange Effects -0.087 0.003 -0.011 0.005 -0.003
Net Change in Cash -15.754 54.149 68.129 82.706 95.849
Cash Interest Paid 0.007
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Satterfield (Thomas A Jr) Individual Investor 7.2983 2197825 623278 2022-12-31 LOW
Vifor (International), Ltd Corporation 6.6269 1995643 0 2023-03-15 LOW
EISA-ABC LLC Corporation 5.719 1722237 0 2023-03-15 LOW
Goldberg (Itzhak D) Individual Investor 5.6193 1692199 4213 2023-03-15 LOW
Venkatesan (Jay R) Individual Investor 3.9765 1197498 0 2023-03-15 LOW
BVF Partners L.P. Hedge Fund 3.5574 1071297 0 2022-12-31 LOW
Nantahala Capital Management, LLC Hedge Fund 3.4308 1033145 -32867 2022-12-31 MED
Ganzi (Victor F.) Individual Investor 3.25 978698 0 2023-03-15 LOW
CM Management, LLC Investment Advisor 2.4313 732178 132178 2022-12-31 MED
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.1386 644035 675 2022-12-31 LOW
Park West Asset Management LLC Hedge Fund 1.2311 370724 0 2022-12-31 MED
Bridgeway Capital Management, LLC Investment Advisor 0.5811 175000 0 2022-12-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.5593 168436 -451 2022-12-31 LOW
Renaissance Technologies LLC Hedge Fund 0.4041 121700 -87277 2022-12-31 HIGH
Omenn (Gilbert S) Individual Investor 0.2667 80326 0 2023-03-15 LOW
Millennium Management LLC Hedge Fund 0.2502 75342 -50261 2022-12-31 HIGH
Raymond James & Associates, Inc. Research Firm 0.1992 60000 0 2022-12-31 LOW
Birchview Capital, LP Investment Advisor 0.1806 54392 0 2022-12-31 LOW
Ergoteles Capital Hedge Fund 0.1757 52913 -25944 2022-12-31 HIGH
BlackRock Institutional Trust Company, N.A. Investment Advisor 0.1696 51069 1188 2022-12-31 LOW

Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

Capital.com Group

500K+

Trader

92K+

Klien aktif per bulan

$53M+

Volume investasi per bulan

$30M+

Penarikan tiap bulan

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long
Industry: Biotechnology & Medical Research (NEC)

7-57 Wells Avenue
NEWTON
MASSACHUSETTS 02459
US

Income Statement

  • Annual
  • Quarterly

People also watch

Gold

1,969.66 Price
-0.550% 1D Chg, %
Biaya inap posisi Long -0.0185%
Biaya inap posisi short 0.0102%
Waktu biaya inap 21:00 (UTC)
Spread 0.30

Natural Gas

2.20 Price
+3.540% 1D Chg, %
Biaya inap posisi Long -0.4044%
Biaya inap posisi short 0.3825%
Waktu biaya inap 21:00 (UTC)
Spread 0.005

Oil - Crude

75.76 Price
+1.830% 1D Chg, %
Biaya inap posisi Long -0.0156%
Biaya inap posisi short -0.0063%
Waktu biaya inap 21:00 (UTC)
Spread 0.03

US100

13,186.80 Price
+1.680% 1D Chg, %
Biaya inap posisi Long -0.0249%
Biaya inap posisi short 0.0027%
Waktu biaya inap 21:00 (UTC)
Spread 3.0

Masih mencari broker yang bisa Anda percayai?

Bergabung dengan 500.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda